Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited)

v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenues, net $ 19,303 $ 47,531
Cost of revenues 8,783 18,854
Gross profit 10,520 28,677
Operating expenses:    
Diagnostic expenses 1,203 4,672
General and administration 8,298 7,824
Research and development 144 35
Total operating expenses 9,645 12,531
Income from operations 875 16,146
Interest income, net 11 73
Interest expense (215) (233)
Other income (loss) (107) (76)
Income from operations before income taxes 564 15,910
Income tax expense 14 3,416
Income from operations after income taxes 550 12,494
Net income 550 12,494
Other comprehensive (loss) income:    
Unrealized loss on marketable debt securities (665) 37
Total comprehensive (loss) income $ (115) $ 12,531
Earnings per share:    
Earnings (loss) per share, basic (in dollars per share) $ 0.03 $ 0.81
Earnings (loss) per share, diluted (in dollars per share) $ 0.03 $ 0.68
Weighted average common shares outstanding:    
Weighted average common shares outstanding, basic (in shares) 16,748 15,486
Weighted average common shares outstanding, diluted (in shares) 18,061 18,740